ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth
- 23 November 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 31 (3), 473-492
- https://doi.org/10.1038/sj.npp.1300958
Abstract
This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.Keywords
This publication has 57 references indexed in Scilit:
- Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control studyBMJ, 2005
- Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trialsBMJ, 2005
- Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety reviewBMJ, 2005
- Antidepressants and public health in IcelandThe British Journal of Psychiatry, 2004
- Trends in Hanging and Firearm Suicide Rates in Australia: Substitution of Method?Suicide and Life-Threatening Behavior, 2003
- Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysisBMJ, 2003
- Antidepressant medication and suicide in SwedenPharmacoepidemiology and Drug Safety, 2001
- The utilization of antidemessants — a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992‐1994Acta Psychiatrica Scandinavica, 1997
- The Treatment of Depression with Paroxetine in Psychiatric Practice in Germany:Pharmacopsychiatry, 1997
- Antidepressant induced suicidal ideationHuman Psychopharmacology: Clinical and Experimental, 1991